A drug used to treat rheumatoid arthritis may reduce the risk of dying for elderly patients with COVID-19, and provide a new weapon in the arsenal against the novel coronavirus, according to a study. “We urgently need to find more effective treatments for COVID-19 while we wait for a vaccine to become widely available, said Professor Justin Stebbing, co-lead author …
The researchers found that the levels of a particular cytokine in the blood upon diagnosis could be used to predict later outcomes. Doctors can examine the blood of COVID-19 patients to identify those at greatest risk of severe illness and to pinpoint those most likely to need a ventilator, according to researchers, including one of Indian-origin. Cytokines — proteins produced …
)
)